Approximately 40% of men diagnosed with prostate cancer will undergo radical prostatectomy.1 Of these, 15% to 46% will manifest an isolated, asymptomatic rise in postoperative PSA within 15 years. This phenomenon is referred to as biochemical recurrence. Since an estimated 75,000 radical prostatectomies are performed annually in the US, biochemical recurrence after prostatectomy represents a healthcare issue of considerable magnitude, affecting several thousand men each year.2.
|Original language||English (US)|
|Title of host publication||Prostate Cancer|
|Subtitle of host publication||Principles and Practice|
|Number of pages||8|
|State||Published - Jan 1 2005|
ASJC Scopus subject areas